FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 343:448 August 10, 2000 Number 6

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by James J. Ferguson III, Nicolas A.F. Chronos, and Robert A. Harrington. 364 pp., illustrated. London, Martin Dunitz, 2000. £65. ISBN 1-85317-624-9.

At one time, antiplatelet therapy was limited to aspirin and dipyridamole as secondary or primary preventive agents. Today, however, we are facing a dramatic revolution in this field with the rapid development of receptor antagonists, inhibitors of platelet adhesion, and metabolic inhibitors.

Antiplatelet Therapy in Clinical Practice attempts to introduce this revolution to physicians practicing primarily in the field of cardiovascular medicine. The list of contributors illustrates that many specialists in this discipline are now also platelet experts. The book has four sections: an introduction to coagulation and platelet function, a section on the various antiplatelet agents, a section on . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.